High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis

Background Lupus nephritis (LN) is a common serious presentation of systemic lupus erythematosus. Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are listed as the first-line drugs in induction therapy for LN. Objective This study aimed to compare high- and low-dose CYC in a cohort of Egyptia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Zeitschrift für Rheumatologie 2024-02, Vol.83 (Suppl 1), p.115-123
Hauptverfasser:	Elaziz, Mohamed Momtaz A., Gamal, Sherif M., Fayed, Ahmed, Abu-Zaid, Mohammed Hassan, Ghoniem, Shada A., Teleb, Doaa A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cyclophosphamide - adverse effects Egypt - epidemiology Humans Immunology Immunosuppressive Agents - therapeutic use Internal Medicine Laboratory Medicine Lupus Nephritis - diagnosis Lupus Nephritis - drug therapy Medicine Medicine & Public Health Mycophenolic Acid - adverse effects Originalien Orthopedics Remission Induction Retrospective Studies Rheumatology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!